Translational Development Acquisition (TDAC) Earnings Analysis
Translational Development Acquisition (TDAC) has no confirmed upcoming earnings date. Trailing P/E 37.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TDAC next report earnings?
No confirmed upcoming earnings date is currently scheduled for TDAC. This page updates as the calendar is published.
TDAC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | 0.0608 USD | n/a | n/a | n/a |
| 2026-03-16 | 0.0728 USD | n/a | n/a | n/a |
TDAC valuation and analyst view
| Trailing P/E | 37.33 |
|---|---|
| Trailing EPS | 0.36012 USD |
| Price / book | 1.05 |
| Dividend yield | 0.00% |
| Market cap | 0.26B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Translational Development Acquisition (TDAC)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for TDAC. This page updates as the calendar is published.
Did TDAC beat earnings last quarter?
Consensus estimate data was not available for TDAC's 2026-05-15 report.
What is TDAC's current P/E ratio and EPS?
TDAC trades at a trailing P/E of 37.33 on trailing EPS of 0.36012463768115943 USD.
What do analysts rate TDAC?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).